Literature DB >> 31021855

Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.

Nicole A Cipriani1, Jonathan J Lusardi2, James McElherne1,3, Alexander T Pearson4, Andrea D Olivas1, Carrie Fitzpatrick1,3, Mark W Lingen1, Elizabeth A Blair5.   

Abstract

Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy, but categorization is complicated by variability in grading systems and uncertain prognostic significance of MAML2 rearrangement. The aims of this study were to determine the prognostic significance of MEC grading systems and MAML2 rearrangement status. Fifty-three carcinomas originally diagnosed as MEC (45 primary; 8 recurrent) of major and minor salivary glands were graded according to modified Healey, Brandwein, AFIP, and Katabi systems. Fluorescence in situ hybridization for MAML2 rearrangement was performed. Clinical features and outcomes were recorded. Twenty-five (47%) carcinomas scored the same in all grading systems. The most common histologic feature leading to a diagnosis of intermediate grade was isolated solid growth. Brandwein assigned the highest percentage of high grade (29%) and AFIP the highest percentage of low grade (80%). MAML2 was rearranged in 37/46 (80%) cases. Forty-three (81%) were morphologically compatible with MEC, and these were more likely to be low-intermediate grade and MAML2-rearranged. Of primary carcinomas, 6 (13%) recurred. Statistically significant univariate risk factors for recurrence included non-MEC morphology, stage T4, and high Brandwein grade. Margin status, MAML2 rearrangement, and isolated solid growth were not predictive of recurrence. A binary grading system (Brandwein high vs. low-plus-intermediate) could be considered to better reflect biological behavior in MEC. Our study confirms that MAML2 wildtype tumors more likely represent high grade non-MECs, and prior studies demonstrating worse prognosis in MAML2-nonrearranged MECs may be diluted by high-grade non-MECs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31021855      PMCID: PMC6629427          DOI: 10.1097/PAS.0000000000001252

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  35 in total

1.  Tumors of the major salivary glands.

Authors:  F W FOOTE; E L FRAZELL
Journal:  Cancer       Date:  1953-11       Impact factor: 6.860

2.  Muco-Epidermoid Tumors of Salivary Glands.

Authors:  F W Stewart; F W Foote; W F Becker
Journal:  Ann Surg       Date:  1945-11       Impact factor: 12.969

3.  MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.

Authors:  Mitsukuni Okabe; Satoru Miyabe; Hitoshi Nagatsuka; Akihiro Terada; Nobuhiro Hanai; Motoo Yokoi; Kazuo Shimozato; Tadaaki Eimoto; Shigeo Nakamura; Noriyuki Nagai; Yasuhisa Hasegawa; Hiroshi Inagaki
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

4.  Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading.

Authors:  M S Brandwein; K Ivanov; D I Wallace; J J Hille; B Wang; A Fahmy; C Bodian; M L Urken; D R Gnepp; A Huvos; H Lumerman; S E Mills
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

5.  CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.

Authors:  Yamilet Tirado; Michelle D Williams; Ehab Y Hanna; Frederic J Kaye; John G Batsakis; Adel K El-Naggar
Journal:  Genes Chromosomes Cancer       Date:  2007-07       Impact factor: 5.006

6.  Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.

Authors:  Afrouz Behboudi; Fredrik Enlund; Marta Winnes; Ywonne Andrén; Anders Nordkvist; Ilmo Leivo; Emilie Flaberg; Laszlo Szekely; Antti Mäkitie; Reidar Grenman; Joachim Mark; Göran Stenman
Journal:  Genes Chromosomes Cancer       Date:  2006-05       Impact factor: 5.006

7.  Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan.

Authors:  Marco Guzzo; Salvatore Andreola; Grazia Sirizzotti; Giulio Cantu
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

Review 8.  Salivary mucoepidermoid carcinoma: revisited.

Authors:  Mario A Luna
Journal:  Adv Anat Pathol       Date:  2006-11       Impact factor: 3.875

9.  Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases.

Authors:  P L Auclair; R K Goode; G L Ellis
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

10.  A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands.

Authors:  Carmo Martins; Branca Cavaco; Giovanni Tonon; Frederic J Kaye; Jorge Soares; Isabel Fonseca
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

View more
  18 in total

1.  Salivary Gland Cancer in the Era of Routine Next-Generation Sequencing.

Authors:  Emilija Todorovic; Brendan C Dickson; Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2020-03-02

Review 2.  The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.

Authors:  Kanwalpreet Kaur; Shailee Mehta; Sangita Vanik; Priti Trivedi; Nirmalya Banerjee; Harsh Dhar; Sourav Datta; Subhadeep Karanjai
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-10       Impact factor: 2.503

3.  Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.

Authors:  Daniel N Johnson; Mine Onenerk; Jeffrey F Krane; Esther Diana Rossi; Zubair Baloch; Güliz Barkan; Massimo Bongiovanni; Fabiano Callegari; Sule Canberk; Glen Dixon; Andrew Field; Christopher C Griffith; Nirag Jhala; Sara Jiang; Daniel Kurtycz; Lester Layfield; Oscar Lin; Zahra Maleki; Miguel Perez-Machado; Marc Pusztaszeri; Philippe Vielh; He Wang; Matthew A Zarka; William C Faquin
Journal:  Cancer Cytopathol       Date:  2020-04-08       Impact factor: 5.284

4.  Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases.

Authors:  Saverio Capodiferro; Giuseppe Ingravallo; Luisa Limongelli; Mauro Giuseppe Mastropasqua; Angela Tempesta; Gianfranco Favia; Eugenio Maiorano
Journal:  J Clin Med       Date:  2020-04-18       Impact factor: 4.241

5.  Adenocarcinoma of the minor salivary gland with concurrent MAML2 and EWSR1 alterations.

Authors:  Sangjoon Choi; Junhun Cho; Seung Eun Lee; Chung-Hwan Baek; Yi-Kyung Kim; Hyung-Jin Kim; Young Hyeh Ko
Journal:  J Pathol Transl Med       Date:  2021-01-22

6.  Expression of Mucins in Salivary Gland Mucoepidermoid Carcinoma.

Authors:  Liam Robinson; Marlene B van Heerden; Jason G Ker-Fox; Keith D Hunter; Willie F P van Heerden
Journal:  Head Neck Pathol       Date:  2020-09-21

7.  Differentiating low and high grade mucoepidermoid carcinoma of the salivary glands using CT radiomics.

Authors:  Michael H Zhang; Adam Hasse; Timothy Carroll; Alexander T Pearson; Nicole A Cipriani; Daniel T Ginat
Journal:  Gland Surg       Date:  2021-05

8.  Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.

Authors:  Yoshihide Okumura; Satsuki Nakano; Takayuki Murase; Kaori Ueda; Daisuke Kawakita; Toshitaka Nagao; Kimihide Kusafuka; Makoto Urano; Hidetaka Yamamoto; Satoshi Kano; Kiyoaki Tsukahara; Kenji Okami; Toru Nagao; Nobuhiro Hanai; Hiroshi Iwai; Ryo Kawata; Yuichiro Tada; Ken-Ichi Nibu; Hiroshi Inagaki
Journal:  Cancer Sci       Date:  2020-09-14       Impact factor: 6.716

9.  Targeted-Gene Sequencing and Bioinformatics Analysis of Patients with Pancreatic Mucoepidermoid Carcinoma: A Case Report and Literature Review.

Authors:  Zhitao Chen; Lele Zhang; Jiacheng Huang; Chenchen Ding; Ting Zhang; Dalong Wan; Liang Xue
Journal:  Onco Targets Ther       Date:  2021-06-03       Impact factor: 4.147

10.  Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping.

Authors:  André Fehr; Sarah Werenicz; Pietro Trocchi; Markus Falk; Reinhard E Friedrich; Angelika Stammler; Andreas Stang; Florian Oesterling; Laura Khil; Göran Stenman; Werner Böcker; Katharina Tiemann; Thomas Löning
Journal:  Virchows Arch       Date:  2021-07-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.